{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:13:45Z","timestamp":1793236425116,"version":"4.5.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:00:00Z","timestamp":1546560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Polycystic ovary syndrome (PCOS) is a major contributor to subfertility, diabetes and cardiovascular disease in women. The role of non-pharmacological interventions to prevent these outcomes has been reported in many systematic reviews, but robust conclusions have not been made due to variations in the scope, quality and findings of these reviews.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>OBJECTIVE AND RATIONALE<\/jats:title>\n                  <jats:p>Our aim was to provide an overview of existing evidence on the effects of non-pharmacological interventions in women with PCOS on fertility and non-fertility outcomes by a review of existing systematic reviews.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SEARCH METHODS<\/jats:title>\n                  <jats:p>We reviewed systematic reviews of randomized trials that have evaluated the effects of non-pharmacological interventions, such as lifestyle interventions, nutritional supplements or alternative medicine therapies in women with PCOS on fertility, endocrine, glycaemic and weight-related outcomes. We assessed the quality of systematic reviews with the AMSTAR tool, and reported the outcomes with regard to: fertility (live birth, clinical pregnancy, ovulation and menstrual cycle regularization); endocrine outcomes (Ferriman\u2013Gallwey score, free androgen index, free testosterone and total testosterone levels); and glycaemic (fasting blood insulin, fasting blood glucose, homoeostatic model assessment) and weight-related (BMI) outcomes. We assessed the strength of evidence for significant outcomes as per the grading of recommendations assessment, development and evaluation (GRADE) system.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>OUTCOMES<\/jats:title>\n                  <jats:p>We found twelve eligible systematic reviews which included between three (143 women) and 27 randomized trials (2093 women). Four reviews assessed the effects of lifestyle interventions (diet, physical activity and\/or behavioural interventions); four evaluated nutritional supplements (one each on n-acetylcysteine, omega-3 fatty acids, inositol and vitamin D); and four studied alternative medical therapies (Chinese herbal medicine and acupuncture). All of the included reviews were of high quality and scored between 8 and 11 with the AMSTAR tool (with a maximum score of 11).<\/jats:p>\n                  <jats:p>Randomized evidence is lacking for live birth rate. N-acetylcysteine, inositol and the addition of alternative medicine to ovulation induction agents show preliminary potential to improve fertility (odds ratios (OR) for clinical pregnancy rate range from 1.99 to 4.83). Lifestyle interventions show benefits in improving hirsutism (mean difference (MD): \u22121.01 to \u22121.19). Lifestyle interventions (MD: \u22121.10 to \u22122.02), inositol (MD: \u22122.1) and acupuncture (MD: \u22121.90 to \u22123.43) all show some evidence of improvement in glycaemic outcomes and there is some evidence of reduced BMI with lifestyle interventions (MD: \u22120.15 to \u22121.12). All of these outcomes scored either low or very low quality of evidence on the GRADE score.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS<\/jats:title>\n                  <jats:p>Lifestyle interventions in women with PCOS appear to improve glycaemic results, androgenic symptoms and anthropometric outcomes. The role of inositol and N-acetylcysteine in women with PCOS needs further evaluation. Large primary trials on all interventions are needed for an agreed set of core outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humupd\/dmy045","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T20:12:55Z","timestamp":1543435975000},"page":"243-256","source":"Crossref","is-referenced-by-count":54,"title":["Overview of systematic reviews of non-pharmacological interventions in women with polycystic ovary syndrome"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4183-8048","authenticated-orcid":false,"given":"Jyotsna","family":"Pundir","sequence":"first","affiliation":[{"name":"Centre for Reproductive Medicine, St. Bartholomew\u2019s Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Charles","sequence":"additional","affiliation":[{"name":"Barts and the London School of Medicine, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sabatini","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, St. Bartholomew\u2019s Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Hiam","sequence":"additional","affiliation":[{"name":"Institute of Health and Sport, Victoria University, Footscray, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Jitpiriyaroj","sequence":"additional","affiliation":[{"name":"Monash Centre for Health Research and Implementation, Monash University, Clayton, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Teede","sequence":"additional","affiliation":[{"name":"Monash Centre for Health Research and Implementation, Monash University, Clayton, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arri","family":"Coomarasamy","sequence":"additional","affiliation":[{"name":"Tommy\u2019s National Centre for Miscarriage Research, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5772-6484","authenticated-orcid":false,"given":"Lisa","family":"Moran","sequence":"additional","affiliation":[{"name":"Monash Centre for Health Research and Implementation, Monash University, Clayton, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakila","family":"Thangaratinam","sequence":"additional","affiliation":[{"name":"Women\u2019s Health Research Unit, The Blizard Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,1,4]]},"reference":[{"key":"2020071623362657500_dmy045C1","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2005-0628","article-title":"Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span","volume":"90","author":"Azziz","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623362657500_dmy045C2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/met.2009.0052","article-title":"Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women with polycystic ovary syndrome","volume":"8","author":"Baillargeon","year":"2010","journal-title":"Metab Syndr Relat Disord"},{"key":"2020071623362657500_dmy045C3","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/oxfordjournals.humrep.a136243","article-title":"Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients","volume":"10","author":"Balen","year":"1995","journal-title":"Hum Reprod"},{"key":"2020071623362657500_dmy045C4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/humupd\/dmw025","article-title":"The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance","volume":"22","author":"Balen","year":"2016","journal-title":"Hum Reprod Update"},{"key":"2020071623362657500_dmy045C5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1055\/s-0031-1293204","article-title":"Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review","volume":"29","author":"Boots","year":"2011","journal-title":"Semin Reprod Med"},{"key":"2020071623362657500_dmy045C6","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"2020071623362657500_dmy045C7","first-page":"3095","article-title":"Inositol: effects on oocyte quality in patients undergoing ICSI. An open study","volume":"17","author":"Brusco","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2020071623362657500_dmy045C8","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/humrep\/dex044","article-title":"High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"32","author":"Cooney","year":"2017","journal-title":"Hum Reprod"},{"key":"2020071623362657500_dmy045C9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/AOG.0000000000000958","article-title":"Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: a randomized controlled trial","volume":"126","author":"D'Anna","year":"2015","journal-title":"Obstet Gynecol"},{"key":"2020071623362657500_dmy045C10","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1210\/jc.2013-2385","article-title":"Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis","volume":"98","author":"Domecq","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623362657500_dmy045C11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623362657500_dmy045C12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ctcp.2016.11.008","article-title":"Effect of vitamin D supplementation on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Fang","year":"2017","journal-title":"Complement Ther Clin Pract"},{"key":"2020071623362657500_dmy045C13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejogrb.2005.03.010","article-title":"Obesity and extreme obesity, manifest by ages 20-24 years, continuing through 32-41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy","volume":"122","author":"Glueck","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2020071623362657500_dmy045C14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4158\/EP.7.2.120","article-title":"American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders","volume":"7","author":"Goodman","year":"2001","journal-title":"Endocr Pract"},{"key":"2020071623362657500_dmy045C15","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"Br Med J"},{"key":"2020071623362657500_dmy045C16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1530\/EC-14-0010","article-title":"Effect of lifestyle intervention on the reproductive endocrine profile in women with polycystic ovarian syndrome: a systematic review and meta-analysis","volume":"3","author":"Haqq","year":"2014","journal-title":"Endocr Connect"},{"key":"2020071623362657500_dmy045C17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1123\/ijsnem.2013-0232","article-title":"The effect of lifestyle intervention on body composition, glycemic control, and cardiorespiratory fitness in polycystic ovarian syndrome: a systematic review and meta-analysis","volume":"25","author":"Haqq","year":"2015","journal-title":"Int J Sport Nutr Exerc Metab"},{"key":"2020071623362657500_dmy045C18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bpobgyn.2004.05.001","article-title":"Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome","volume":"18","author":"Hart","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2020071623362657500_dmy045C19","doi-asserted-by":"crossref","first-page":"e7066","DOI":"10.1097\/MD.0000000000007066","article-title":"Acupuncture for polycystic ovarian syndrome: a systematic review and meta-analysis","volume":"96","author":"Jo","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"2020071623362657500_dmy045C20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071623362657500_dmy045C21","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1210\/jc.2015-2778","article-title":"Randomized controlled trial of preconception interventions in infertile women with polycystic ovary syndrome","volume":"100","author":"Legro","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623362657500_dmy045C22","first-page":"CD007689","article-title":"Acupuncture for polycystic ovarian syndrome","volume":"5","author":"Lim","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2020071623362657500_dmy045C23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"2020071623362657500_dmy045C24","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"Br Med J"},{"key":"2020071623362657500_dmy045C25","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1472-6483(10)61182-0","article-title":"Effects of lifestyle modification in polycystic ovarian syndrome","volume":"12","author":"Moran","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"2020071623362657500_dmy045C26","first-page":"CD007506","article-title":"Lifestyle changes in women with polycystic ovary syndrome","volume":"7","author":"Moran","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2020071623362657500_dmy045C27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.rbmo.2009.12.012","article-title":"Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study","volume":"20","author":"Nasr","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"2020071623362657500_dmy045C28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejogrb.2009.09.008","article-title":"Contribution of myo-inositol to reproduction","volume":"147","author":"Papaleo","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2020071623362657500_dmy045C30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/1471-0528.14754","article-title":"Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials","volume":"125","author":"Pundir","year":"2017","journal-title":"BJOG"},{"key":"2020071623362657500_dmy045C31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1477-7827-11-56","article-title":"Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"11","author":"Qin","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"2020071623362657500_dmy045C32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.eujim.2016.02.001","article-title":"The effects of acupuncture on polycystic ovary syndrome: a systematic review and meta-analysis","volume":"1","author":"Qu","year":"2016","journal-title":"Eur J Integr Med"},{"key":"2020071623362657500_dmy045C33","first-page":"5491","article-title":"Can high levels of D-chiro-inositol in follicular fluid exert detrimental effects on blastocyst quality?","volume":"21","author":"Ravanos","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2020071623362657500_dmy045C34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","journal-title":"Fertil Steril"},{"key":"2020071623362657500_dmy045C35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.dsx.2016.06.025","article-title":"Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials","volume":"11","author":"Sadeghi","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"2020071623362657500_dmy045C36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews","volume":"7","author":"Shea","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"2020071623362657500_dmy045C37","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1590\/1516-3180.2013.8150015","article-title":"Overview of systematic reviews\u2014a new type of study. Part II","volume":"133","author":"Silva","year":"2015","journal-title":"Sao Paulo Med J"},{"key":"2020071623362657500_dmy045C38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2288-11-15","article-title":"Methodology in conducting a systematic review of systematic reviews of healthcare interventions","volume":"11","author":"Smith","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"2020071623362657500_dmy045C39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med"},{"key":"2020071623362657500_dmy045C40","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"2020071623362657500_dmy045C41","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.5694\/mja11.10915","article-title":"Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline","volume":"195","author":"Teede","year":"2011","journal-title":"Med J Aust"},{"key":"2020071623362657500_dmy045C42","doi-asserted-by":"crossref","first-page":"817849","DOI":"10.1155\/2015\/817849","article-title":"N-Acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials","volume":"2015","author":"Thakker","year":"2015","journal-title":"Obstet Gynecol Int"},{"key":"2020071623362657500_dmy045C43","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.fertnstert.2008.06.045","article-title":"Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis","volume":"92","author":"Toulis","year":"2009","journal-title":"Fertil Steril"},{"key":"2020071623362657500_dmy045C44","first-page":"377","volume-title":"Diagnostic Criteria for Polycystic Ovary Syndrome: Towards a Rational Approach","author":"Zawadski","year":"1992"},{"key":"2020071623362657500_dmy045C45","first-page":"CD007535","article-title":"Chinese herbal medicine for subfertile women with polycystic ovarian syndrome","volume":"10","author":"Zhou","year":"2016","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Human Reproduction Update"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humupd\/article-pdf\/25\/2\/243\/27983519\/dmy045.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humupd\/article-pdf\/25\/2\/243\/27983519\/dmy045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T13:05:55Z","timestamp":1594991155000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humupd\/article\/25\/2\/243\/5272755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,4]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,1,4]]},"published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humupd\/dmy045","relation":{},"ISSN":["1355-4786","1460-2369"],"issn-type":[{"value":"1355-4786","type":"print"},{"value":"1460-2369","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3]]},"published":{"date-parts":[[2019,1,4]]}}}